Filing Details

Accession Number:
0001140361-18-020866
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-01 17:14:50
Reporting Period:
2018-04-27
Accepted Time:
2018-05-01 17:14:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1130598 Onconova Therapeutics Inc. ONTX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1404574 683 Capital Management, Llc 3 Columbus Circle
Suite 2205
New York NY 10019
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Acquisiton 2018-04-27 11,838,235 $0.43 14,503,169 No 4 P Indirect By 683 Capital Partners, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By 683 Capital Partners, LP
Footnotes
  1. This Form 4 is filed jointly by 683 Capital Management, LLC ("683 Management"), 683 Capital Partners, LP ("683 Partners") and Ari Zweiman (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
  2. Represents securities held directly by 683 Partners. 683 Management is the investment manager of 683 Partners. Ari Zweiman is the Managing Member of 683 Management. As a result, each of 683 Management and Ari Zweiman may be deemed to beneficially own the securities held by 683 Partners.